BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33619026)

  • 1. Hysterectomy and Risk of Breast, Colorectal, Thyroid, and Kidney Cancer - an Australian Data Linkage Study.
    Wilson LF; Tuesley KM; Webb PM; Dixon-Suen SC; Stewart LM; Jordan SJ
    Cancer Epidemiol Biomarkers Prev; 2021 May; 30(5):904-911. PubMed ID: 33619026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hysterectomy with and without oophorectomy and all-cause and cause-specific mortality.
    Tuesley KM; Protani MM; Webb PM; Dixon-Suen SC; Wilson LF; Stewart LM; Jordan SJ
    Am J Obstet Gynecol; 2020 Nov; 223(5):723.e1-723.e16. PubMed ID: 32376318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hysterectomy, Oophorectomy, and Risk of Thyroid Cancer.
    Luo J; Hendryx M; Manson JE; Liang X; Margolis KL
    J Clin Endocrinol Metab; 2016 Oct; 101(10):3812-3819. PubMed ID: 27459531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oophorectomy and hysterectomy and cancer incidence in the Cancer Prevention Study-II Nutrition Cohort.
    Gaudet MM; Gapstur SM; Sun J; Teras LR; Campbell PT; Patel AV
    Obstet Gynecol; 2014 Jun; 123(6):1247-1255. PubMed ID: 24807324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of risk-reducing hysterectomy and bilateral salpingo-oophorectomy on survival in patients with a history of breast cancer--a population-based data linkage study.
    Obermair A; Youlden DR; Baade PD; Janda M
    Int J Cancer; 2014 May; 134(9):2211-22. PubMed ID: 24127248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do breast cancer survivors benefit from prophylactic removal of uterus and ovaries? A population-based data linkage replication study.
    Obermair A; Youlden D; Baade P; Janda M
    Asia Pac J Clin Oncol; 2017 Feb; 13(1):68-78. PubMed ID: 27230709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Association Between Hysterectomy and Ovarian Cancer Risk: A Population-Based Record-Linkage Study.
    Dixon-Suen SC; Webb PM; Wilson LF; Tuesley K; Stewart LM; Jordan SJ
    J Natl Cancer Inst; 2019 Oct; 111(10):1097-1103. PubMed ID: 30753695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hysterectomy status and all-cause mortality in a 21-year Australian population-based cohort study.
    Wilson LF; Pandeya N; Byles J; Mishra GD
    Am J Obstet Gynecol; 2019 Jan; 220(1):83.e1-83.e11. PubMed ID: 30312584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilateral oophorectomy and risk of cancer in African American women.
    Boggs DA; Palmer JR; Rosenberg L
    Cancer Causes Control; 2014 Apr; 25(4):507-13. PubMed ID: 24487726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hysterectomy, bilateral oophorectomy, and breast cancer risk in a racially diverse prospective cohort study.
    Lovett SM; Sandler DP; O'Brien KM
    J Natl Cancer Inst; 2023 Jun; 115(6):662-670. PubMed ID: 36806439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent uterine surgery and uptake of hormone therapy in patients undergoing bilateral salpingo-oophorectomy for risk-reducing or therapeutic indications.
    Sasse SA; Lee SS; Rajeev P; Sharma SR; Kahan T; Pothuri B
    Gynecol Oncol; 2023 Dec; 179():131-137. PubMed ID: 37988946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian removal and subsequent breast cancer prognosis: a nationwide cohort study.
    Gottschau M; Kjær SK; Viuff JH; Jensen A; Munk C; Settnes A; Mellemkjær L
    Breast Cancer Res Treat; 2023 Feb; 197(3):583-591. PubMed ID: 36482232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer risk after hysterectomy with and without salpingo-oophorectomy for benign indications.
    Chow S; Raine-Bennett T; Samant ND; Postlethwaite DA; Holzapfel M
    Am J Obstet Gynecol; 2020 Dec; 223(6):900.e1-900.e7. PubMed ID: 32585221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prior hysterectomy and oophorectomy and incident venous thrombosis risk among postmenopausal women: a population-based, case-control study.
    Harrington LB; Weiss NS; Wiggins KL; Heckbert SR; McKnight B; Blondon M; Woods NF; LaCroix AZ; Psaty BM; Smith NL
    Menopause; 2016 Feb; 23(2):143-9. PubMed ID: 26757272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian removal at or after benign hysterectomy and breast cancer: a nationwide cohort study.
    Gottschau M; Kjær SK; Settnes A; Aalborg GL; Bens A; Jensen A; Munk C; Mellemkjær L
    Breast Cancer Res Treat; 2020 Jun; 181(2):475-485. PubMed ID: 32328847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid cancer risk in women after hysterectomy: A nationwide cohort study.
    Tai TS; Tsai CF; Yang HY
    Maturitas; 2024 Jul; 185():107980. PubMed ID: 38555761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid cancer after hysterectomy and oophorectomy: a nationwide cohort study.
    Kim M; Kim BH; Lee H; Nam H; Park S; Jang MH; Kim JM; Kim EH; Jeon YK; Kim SS; Kim IJ
    Eur J Endocrinol; 2021 Jan; 184(1):143-151. PubMed ID: 33112277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation between hysterectomy, oophorectomy and the risk of incident differentiated thyroid cancer: The E3N cohort.
    Guenego A; Mesrine S; Dartois L; Leenhardt L; Clavel-Chapelon F; Kvaskoff M; Boutron-Ruault MC; Bonnet F
    Clin Endocrinol (Oxf); 2019 Feb; 90(2):360-368. PubMed ID: 30390407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term cancer risk after hysterectomy on benign indications: Population-based cohort study.
    Altman D; Yin L; Falconer H
    Int J Cancer; 2016 Jun; 138(11):2631-8. PubMed ID: 26800386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hysterectomy and Bilateral Salpingo-Oophorectomy: Variations by History of Military Service and Birth Cohort.
    Callegari LS; Gray KE; Zephyrin LC; Harrington LB; Gerber MR; Cochrane BB; Weitlauf JC; Bean-Mayberry B; Bastian LA; Mattocks KM; Haskell SG; Katon JG
    Gerontologist; 2016 Feb; 56 Suppl 1(Suppl 1):S67-77. PubMed ID: 26768393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.